FDA Will Not Appeal Ruling Against LDT Regulation, Giving a Big Victory to Labs
The legal strategy of the ACLA—and some political luck—prevailed in the lawsuit against LDT oversight
Lab Industry Advisor
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Subscribe today for access to
Articles and Reports
Expanding Test Menus: A Compliance Roadmap for FDA-Regulated Labs
Two OIG advisory opinions guide laboratories that want to work with pharma or medical device companies on expanded testing
Dx Deals: Labcorp Continues Dealmaking with Incyte Asset Acquisition in Washington State
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
G2 Compliance Corner
...
Already a member? Log in here
Medical Center Reports Security Breach Affecting 90,000 Patients
...
Already a member? Log in here
Ameritox Alleges Destruction of Evidence by Top Millennium Executives
...
Already a member? Log in here
Audit Finds Three Major Deficiencies In Oversight of Security Rule
...
Already a member? Log in here
Final FDA Guidance on RUO, IUO Products Raises Compliance Concerns for Labs
...
Already a member? Log in here
News-At-A-Glance: Pennsylvania Hospital Pays $2 Million After Self-Disclosure
...
Already a member? Log in here